Episode Details
Back to Episodes
JP Morgan David Happel
Published 1 year, 6 months ago
Description
Our little spin off of our time at JPM!
Big announcements and exclusives! Here we have David Happel, CEO of Sagimet Biosciences
Listen to hear how they've been doing.